Work

FRI0303 Efficacy and safety of ustekinumab in patients with active systemic lupus erythematosus: results of a phase 2, randomised placebo-controlled study

Year: 2018

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2018-eular.1734

Authors: R. van Vollenhoven, B.H. Hahn, G.C. Tsokos, C. Wagner, P. Lipsky, B. Hsu, M. Chevrier, R. Gordon, M. Triebel, S. Rose

Institutions: University of California, Los Angeles, Ampel BioSolutions (United States), Janssen (Netherlands)

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Janssen Research and Development

OpenAlex ID: W2808900547

Cites:

Cited by:

Related to: 10